AI analysis of brain tumor MRI scans
Part of Brain & nervous system, Cancer clinical trials.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had an MRI scan showing a glioma between 2019 and 2024.
- You must have had surgery to remove the entire tumor, with or without follow-up radiation or chemotherapy.
- You must be between 18 and 60 years old.
- Your MRI scans must be of good quality and not have artifacts that interfere with analysis.
- You must not have refused consent to have your data used in research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with glioma who have tumor tissue or blood samples stored. It uses artificial intelligence to analyze these samples and find the best treatment. You might be eligible if you are at least 18 years old and have had a glioma diagnosis with tissue available for study.
This trial uses an AI computer program to predict the molecular features of a primary brain tumor (glioma) by looking at tumor tissue images. Your results could help researchers better match glioma subtypes to more tailored care, using information obtained from the surgery sample.
This study is testing if artificial intelligence (AI) can look at microscope slides of your brain tumor tissue to guess its genetic makeup. It uses data already collected from your routine care, so there is no extra treatment or medicine involved.
This trial uses brain scan images (MRI) and tumor tissue tests to predict how long people with primary glioma may live. The goal is to see if the AI prediction can improve planning and care after surgery.
This trial uses artificial intelligence to analyze MRI scans and help doctors identify the type of brain tumor in children. It aims to improve treatment planning by providing a non-invasive way to predict the tumor subtype before surgery.
This trial uses AI to look at tumor tissue images to predict survival in people with glioma. If you qualify, your surgery tissue and imaging help train tools that may better estimate outcomes and guide care.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.